Indication
Korjuny is indicated for the intraperitoneal treatment of malignant ascites in adults with epithelial cellular adhesion molecule (EpCAM)-positive carcinomas, who are not eligible for further systemic anticancer therapy.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- Korjuny 10 Microgramos Concentrado Para Solucion Para PerfusionSpain · 10 µgAuthorised
- Korjuny 50 Microgramos Concentrado Para Solucion Para PerfusionSpain · 50 µgAuthorised
- Korjuny 10 microgram concentraat voor oplossing voor infusieNetherlandsAuthorised
- Korjuny 50 microgram, concentraat voor oplossing voor infusieNetherlandsAuthorised